What is the market doing?
What the tape says about RVMD
Revolution Medicines, Inc. is +468% over the past year while the S&P 500 is +20%: 448 points ahead of the market.
+468%
1-year return · S&P 500 +20%
- vs 200-day average
- +64%
vs 200-day average · a clear uptrend
- RSI (14)
- 43
RSI (14) · neutral
- Below its 52-week high
- 4.2%
Below its 52-week high
Details›
- Last close2026-09-08
- $207.14
- 1 monthS&P 500 −0.30%
- +4.7%
- 1 yearS&P 500 +20%
- +468%
- 5 yearsS&P 500 +85%
- +670%
- vs 50-day average$189.62
- +9.2%
- 52-week high
- $216.19
- 52-week low
- $35.67
- Annualised volatility
- 57%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$720K
| Year | Return |
|---|---|
| 2026 (year to date) | +160% |
| 2025 | +82% |
| 2024 | +53% |
| 2023 | +20% |
| 2022 | −5.4% |
| 2021 | −36% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 3 of 6 | +3.5% |
| Feb | 6 | 4 of 6 | +0.45% |
| Mar | 7 | 3 of 7 | −3.2% |
| Apr | 7 | 5 of 7 | +11% |
| May | 7 | 3 of 7 | −1.5% |
| Jun | 7 | 6 of 7 | +5.5% |
| Jul | 7 | 4 of 7 | +0.39% |
| Aug | 7 | 5 of 7 | +6.8% |
| Sep | 7 | 4 of 7 | +3.4% |
| Oct | 6 | 4 of 6 | +2.0% |
| Nov | 6 | 5 of 6 | +19% |
| Dec | 6 | 3 of 6 | −2.7% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
Ranks #12 of 143 by Smart Score